The Safety, Tolerability and Preliminary Efficacy of AV411, a Glial Activation Inhibitor, in Heroin Abusers Under Conditions of Morphine Maintenance and Withdrawal
Phase of Trial: Phase II
Latest Information Update: 07 Dec 2016
At a glance
- Drugs Ibudilast (Primary)
- Indications Opioid abuse
- Focus Therapeutic Use
- 11 Oct 2016 Status changed from active, no longer recruiting to completed.
- 16 Jun 2015 According to a MediciNova media release, results published in the journal Addiction Biology.
- 07 Sep 2014 Columbia University and the New York State Psychiatric Institute have received a grant from the National Institute on Drug Abuse (NIDA) to enable completion of this trial.